These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 13269837)

  • 1. ANTIBODY responses and clinical reactions with saline and oil adjuvant influenza virus vaccines.
    The Medical Research Council's Committee
    Br Med J; 1955 Nov; 2(4950):1229-32. PubMed ID: 13269837
    [No Abstract]   [Full Text] [Related]  

  • 2. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1957 Dec; 106(6):835-50. PubMed ID: 13481247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.
    HERBERT WJ; SELWYN S; PHILP JR
    Br J Prev Soc Med; 1965 Apr; 19(2):97-100. PubMed ID: 14319217
    [No Abstract]   [Full Text] [Related]  

  • 6. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion.
    SALK JE; BAILEY ML; LAURENT AM
    Am J Hyg; 1952 May; 55(3):439-56. PubMed ID: 14933383
    [No Abstract]   [Full Text] [Related]  

  • 9. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
    Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous and oil-adjuvant influenza vaccines and isoimmunization to group A substance.
    Forsyth JR; Wilson TE
    J Hyg (Lond); 1968 Mar; 66(1):1-6. PubMed ID: 4869016
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
    Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of oil adjuvant and aqueous influenza vaccines. II. Antibody responses to the vaccines.
    Forsyth JR; Russell EE
    J Hyg (Lond); 1967 Dec; 65(4):497-504. PubMed ID: 5235255
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.
    Mulligan MJ; Bernstein DI; Winokur P; Rupp R; Anderson E; Rouphael N; Dickey M; Stapleton JT; Edupuganti S; Spearman P; Ince D; Noah DL; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1409-19. PubMed ID: 25291577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination.
    SALK JE; CONTAKOS M; LAURENT AM; SORENSEN M; RAPALSKI AJ; SIMMONS IH; SANDBERG H
    J Am Med Assoc; 1953 Apr; 151(14):1169-75. PubMed ID: 13034453
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches to the control of influenza.
    Dowdle WR
    Med J Aust; 1973 Jun; ():S:38-41. PubMed ID: 4717621
    [No Abstract]   [Full Text] [Related]  

  • 18. CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    UJHAZY V
    Br Med J; 1964 Aug; 2(5404):267-71. PubMed ID: 14160206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.